Of note, lower serum BChE levels were associated with lower BMI (p < 0.001), advanced tumor stage (p = 0.04), poor response to treatment (p = 0.002), the occurrence of disease recurrence (p = 0.003), and the risk of death (p < 0.001). This evidence concerns the gene BCHE and neoplasm.